Vesugen – 20mg Research Compound

Vesugen (20mg) — Research Compound

Vesugen is a three-amino-acid peptide bioregulator developed specifically to interact with blood vessel walls and vascular tissue. It works at the cellular level to help blood vessels maintain their structure and normal function. In laboratory studies, Vesugen is researched for its capacity to stimulate blood vessel repair, support capillary blood flow, and improve vessel elasticity.

Findings from early-stage research have reported:

• Increased renewal and repair activity within blood vessel lining cells
• Improvements in the elasticity and physical strength of vessel walls
• Enhanced microcirculation and blood flow in small capillary networks
• Better cellular survival and protection against oxygen deprivation and oxidative stress

Researchers study Vesugen to uncover how vascular tissues adapt and recover from physical wear and age-related changes. Its targeted action on vessel walls makes it an essential compound for investigating cardiovascular health, blood circulation, and the prevention of vascular stiffness.

Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

References

Peptide regulation of vascular endothelial cell proliferation and ageing
This research examined short peptide bioregulators including the vascular-associated peptide Lys-Glu-Asp (KED), the sequence identified for Vesugen. The work provides relevant experimental context for KED-mediated regulation of vascular endothelial cells and age-related cellular processes. Available here

Short peptides regulate gene expression and cellular ageing pathways
This research reviews the molecular mechanisms of short peptide bioregulators, including KED, and describes their interactions with DNA and gene-regulatory processes. It provides relevant mechanistic context for studying Vesugen at the cellular level. Available here

Vascular peptide bioregulators and endothelial tissue research
This publication investigated short peptide effects on vascular tissue, including endothelial cell proliferation and tissue-specific regulatory activity. The findings provide research context for the KED peptide used in Vesugen and its relationship with vascular cellular homeostasis. Available here